Overview

NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After?

Status:
Active, not recruiting
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the usual and the reverse sequence of an anthracycline followed by a taxane in locally advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto Nacional de Cancer, Brazil
Collaborator:
Sanofi
Treatments:
Docetaxel
Taxane